Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

High Dose Supplements to Reduce Homocysteine and Slow the Rate of Cognitive Decline in Alzheimer's Disease (Vitamins to Slow Alzheimer's - VITAL)

NCT00056225 is registered in ClinicalTrials.gov with National Institute on Aging (NIA) as lead sponsor.

NCT NCT00056225
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00056225 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
High Dose Supplements to Reduce Homocysteine and Slow the Rate of Cognitive Decline in Alzheimer's Disease (Vitamins to Slow Alzheimer's - VITAL)
Lead sponsor
National Institute on Aging (NIA)
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2003
Completion date
June 30, 2007
Enrollment
340 (actual)
Sites
38

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease